Profiel
Kan Chen is currently a Non-Executive Director at LongBio Pharma (Suzhou) Co., Ltd. and Ming Yu Pharmaceutical Ltd., both starting in 2025.
Former positions include Director at Jiangsu Yahong Meditech Co., Ltd. from 2020 to 2023; Non-Executive Director at Antengene Corp.
Ltd. from 2021 to 2024; Non-Executive Director at Abbisko Cayman Ltd. from 2020 to 2021; Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2024; Non-Executive Director at Connect Biopharma Holdings Ltd. from 2020 to 2025; and Non-Executive Director at InSilico Medicine Cayman TopCo from 2023 to 2026.
Education includes a doctorate from Harvard Medical School conferred in 2012, a doctorate from Case Western Reserve University conferred in 2009, and an undergraduate degree from Fudan University conferred in 2004.
Actieve functies van Kan Chen
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Kan Chen
| Bedrijven | Functie | Einde |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Directeur/Bestuurslid | 15-07-2026 |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Directeur/Bestuurslid | 01-12-2025 |
| CANBRIDGE PHARMACEUTICALS INC. | Directeur/Bestuurslid | 01-09-2024 |
| ANTENGENE CORPORATION LIMITED | Directeur/Bestuurslid | 01-06-2024 |
| JIANGSU YAHONG MEDITECH CO., LTD. | Directeur/Bestuurslid | 01-12-2023 |
Opleiding van Kan Chen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Yahong Meditech Co., Ltd.
Jiangsu Yahong Meditech Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and commercialization of medicines in the fields of urogenital system tumors and major diseases fields | Health Technology |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
Antengene Corp. Ltd.
Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Abbisko Cayman Ltd.
Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















